Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type (Personal Promotion, Non-personal Promotion, Others), By Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, Others), By End User (Biopharmaceutical Companies, Medical Device Companies, Generic Companies, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024

Code : CMI6549

Pages :160

Formats :

Excel and PDF

Industry : Healthcare IT

Market News

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market- Recent Developments

Service Launch

On June 6, 2023, Aktana a software company launched a new platform named Contextual Intelligence 360 for Pharma Product Launch. This improves the product launch success for life sciences companies facing looming patent cliff and smaller pipeline. Contextual Intelligence 360 for product launch reduces time to market and boosts sales for new drug products. This service launch by Aktana enhances product launch services for pharmaceutical companies.
On October 2, 2023, Trinity a lifescience company introduced Launch Accelerator 2.0 to provide smart, efficient launch planning with customized, tech-enabled support. It is an easy-to-use cloud-based project management tool that leverages recent “real world” launches to guide cross-functional Global Launch and Project Management Office (PMO) teams. It acts as a key development for cloud-based product launches.
In June 2022, EVERSANA a lifescience company launched EVERSANA INTOUCH to serve the life sciences industry. It provides life sciences marketing to accelerate brand performance through insights and seamless connectivity to EVERSANA's integrated commercialization solutions. The EVERSANA INTOUCH acts as a key development to drive the commercialization services to pharmaceutical companies.

Acquisitions and Collaborations

On October 11, 2023, EVERSANA acquired Healthware Group, a full-service agency and innovation consultancy. This acquisition expanded EVERSANA's European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally to launch products, expand market access, or solve unique geographic and market-specific challenges. This acquisition drives the market due to increasing capabilities such as launch of products and expand market access.
On September 13, 2023, Deloitte a consulting firm collaborated with Salesforce, a software company, to help pharmaceutical companies bring innovative therapies to patients faster. This collaboration enhances next generation of innovations that enable the rapid scientific and technological progress in the BioPharma industry.
On November 1, 2023, Aktana acquired Tact.ai's field engagement and conversational Artificial intelligence (AI) This acquisition extended Aktana's leadership in field intelligence by delivering several new capabilities frequently requested by commercial and medical leaders overseeing omnichannel programs. Tact.ai is human-friendly technology that connects life science companies and customers to improve real-time CRM and content syncing.